IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
IMPL
Delisted
IMPL was delisted on the 15th of December, 2023.
32 hedge funds and large institutions have $7.35M invested in Impel Pharmaceuticals Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
67% less capital invested
Capital invested by funds: $22.3M → $7.35M (-$14.9M)
Holders
32
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$9.24K | |
| 2 | +$9.13K | |
| 3 | +$8.8K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.42K |
| 5 |
VF
Virtu Financial
New York
|
+$7K |
Top Sellers
| 1 | -$158K | |
| 2 | -$80.4K | |
| 3 | -$78.5K | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$63K |
| 5 |
DA
DCF Advisers
Greenwich,
Connecticut
|
-$53.8K |